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Abstract
Malignant peripheral nerve sheath tumors are extremely rare tumors arising in periph-
eral nerves. Only 17 cases involving the trigeminal nerve have ever been reported.
These tumors have a very poor prognosis and very high rates of recurrence and metas-
tases. Their recommended treatment involves complete tumor resection followed by
radiation. This can be problematic in the head and neck region. We present a clinical
case involving a 33-year-old female patient presenting with a slow-growing, exo-
phytic mass of the anterior maxilla. Incisional biopsy and subsequent histological
examination revealed a diagnosis of a malignant peripheral nerve sheath tumor. Sur-
gical resection involved a complete maxillectomy, rhinectomy, and resection of the
upper lip and aspects of the left and right cheeks. Reconstruction of the subsequent
defect incorporated the placement of four zygomatic oncology implants to aid in
retention of a facial prosthesis. These implants, however, were subsequently lost;
and an anatomical model of the hard tissues was manufactured via 3D printing. This
model was used to design and manufacture a titanium frame (customized implant) for
the patient. The frame was then fixated and secured intraoperatively with 21 cortical
screws. A maxillary denture and silicone facial prosthesis were also made to fit onto
this frame. This is the first known case where additive manufacturing, via the use of
rapid prototyping and 3D printing, was employed to manufacture a facial prosthesis.
Malignant peripheral nerve sheath tumors (MPNSTs) are ex-
tremely rare tumors arising from the Schwann cells of periph-
eral nerves.1 MPNSTs of the trigeminal nerve are exceedingly
rare1 with only 17 cases being published in the English medical
literature.2,5,6 These tumors have a very poor prognosis1 with
5-year survival rates of only 20% being reported in the head
and neck region.1,8 Local recurrence rates range from 30% to
60% even in cases of complete tumor resection.1,3,7 They have
been shown to metastasize to the lungs, soft tissue, bone, liver,
and/or brain in almost 65% of cases.1-3,10
Due to their aggressive and highly infiltrative nature,1 high
recurrence rate,1,3 and poor prognosis, the recommended treat-
ment for these tumors is aggressive radical resection.1,2,5,11
Complete removal of the lesion with tumor-free margins3,4,9,10
measuring 2 cm in all directions is seldom possible in the head
and neck region, therefore radiation therapy following resec-
tion is recommended. This could offer increased rates of tumor
control and long-term survival.1,2,8,9,11
Clinical report
We present the case of a 33-year-old female patient who pre-
sented in 2011 with a slow-growing exophytic soft tissue mass
of the anterior maxilla in the region of teeth #s 11, 12, 13,
21, and 22 and spreading to the palate. A biopsy of the le-
sion was performed and histologically diagnosed as Kaposi
sarcoma. The patient was referred for chemotherapy but never
received this treatment and no follow-up appointments were
scheduled.
The patient returned a few months later in 2012 present-
ing with an anterior palatal mass, measuring 12×10×8 mm,
infiltrating the underlying maxilla. The lesion appeared to be
secondarily infected, with signs and symptoms of continuous
bleeding and occasional pain. An incisional biopsy was submit-
ted for histological evaluation, which revealed a diagnosis of a
malignant peripheral nerve sheath tumor. This required that the
anterior portion of the maxilla be surgically resected, including
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Figure 1 Malignant peripheral nerve sheath tumor of the face.
Figure 2 Oncology implants placed at time of resection.
Figure 3 Provisional implant-supported acrylic obturator.
Figure 4 Interim facial prosthesis.
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Figure 5 Defect after loss of implants.
Figure 6 Frontal view of 3D planning model indicating the severity of
the defect.
Figure 7 Final 3D CAD design of titanium implant.
Figure 8 3D design of drill guide with drilling angles indicated by the red
lines.
all the anterior teeth, premolars, and the body of the maxilla up
to 2 cm above the nasal floor.
The patient was once again non-compliant, so surgery and
prosthesis fabrication were not performed at this time. She did
return in 2013, presenting with tumor infiltration involving the
left and right alae and the right cheek, as well as an ulcerated le-
sion of the upper lip, causing considerable pain and discomfort.
An incisional biopsy and subsequent histological examination
revealed a diagnosis of a recurrent malignant peripheral nerve
sheath tumor (Fig 1).
This tumor was extending rapidly, and due to a history of non-
compliance by the patient, we had to act quickly. Our team,
comprising two maxillofacial surgeons and a prosthodontist,
planned for the surgical excision of the tumor in its entirety.
Maxillectomy defects
Maxillectomy defects resulting from resective surgery can be
divided into the following types:12
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Figure 9 Polished midfacial titanium implant.
Figure 10 Implant immediately postsurgery.
Figure 11 Maxillary denture with soft base fitting surface.
- Type I—limited maxillectomy defects—partial defects
where the palate and orbital floor remain intact.
- Type II—subtotal maxillectomy defects—involve resec-
tion of most of the maxilla, but the orbital floor remains
intact. In type IIA, the defect incorporates less than 50%
Figure 12 Silicone facial prosthesis.
of the palate, while in type IIB, the defect extends over
more than 50% of the palate.
- Type III—total maxillectomy defects—involve resection
of the entire maxilla, and can exclude (type IIIA) or
include (type IIIB) the orbital contents.
- Type IV—orbitomaxillectomy defects—involve resec-
tion of the upper part of the maxilla and orbital contents
with the palate remaining largely intact.
Due to its extent, a subtotal maxillectomy, rhinectomy, and
resection of the upper lip including some aspects of the left
and right cheeks would have to be performed. This placed our
patient in the type IIB category, because the resultant defect
included the entire palate but the orbital floor and its contents
remained in place.
Reconstruction of such a defect should ideally be done imme-
diately or very soon after the resective procedure, to minimize
psychological and emotional distress on the patient. The con-
siderable gains in microvascular surgical techniques in the past
20 to 30 years have allowed surgeons to be able to reconstruct
significant defects like these in a single procedure. The use
of pedicle flaps from the surrounding regions and free tissue
transfers, including hard and soft tissues, from sites such as the
radial forearm, rectus abdominus, fibula, scapular region, and
the iliac crest, have given surgeons the ability to customize their
reconstructions to match defects.13
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Surgical reconstruction of such a significant defect would
have required an additional team of reconstructive and mi-
crovascular surgeons. Unfortunately, the public health service
in South Africa lacks these highly specialized surgeons. It was
thus decided to reconstruct the defect via an extensive maxillo-
facial prosthodontic rehabilitation. No prior facial impressions
were made before surgery due to a lack of available chair time
in our prosthodontic ward. Following the resective surgery, our
maxillofacial surgeons placed four zygomatic oncology im-
plants (Southern Implants, Pretoria, South Africa). This was
planned to aid in the retention of our prosthesis. At the same
time, and still in the operating theater, our prosthodontist took
an impression of the defect and the position of the implants
(Fig 2).
Zygomatic implants are 35 to 55 mm long and are inserted
into the zygomatic bone. As a result of this increased length,
any movements on the implants will have significant leveraging
effects at their point of insertion, which could interfere with os-
seointegration. At our institution, we try to splint these implants
as quickly as possible. A modified interim implant-supported
obturator prosthesis and interim silicone facial prosthesis were
manufactured and placed 3 days after surgery to establish sep-
arate oral and nasal cavities to improve swallowing, facilitate
saliva control, and enhance speech articulation (Figs 3 and 4).
As a possible result of immediate loading on these implants
and the extensive size of the prosthesis loaded onto them, they
failed to osseointegrate and were lost after 4 weeks. This meant
that the obturator had to be removed (Fig 5). This posed a major
complication for the fabrication of a new prosthesis. The tissues
bordering the defect had no bony foundation, and were easily
compressed and distorted, which made subsequent impression
taking virtually impossible. Traditional and conventional means
for reconstruction were no longer an option, so we decided to
incorporate advanced technology to assist us.
Rapid prototyping and 3D printing
As the name implies, rapid prototyping (RP) refers to the rapid
manufacture of complex 3D models or physical parts (proto-
types) using 3D computer-aided design (CAD) data. It is widely
used in product design in some industries and has found a use in
the medical and dental fields over the past 30 years. In dentistry
it is used specifically for improved and cost-effective diagnosis,
treatment planning, and manufacture of certain types of
prostheses.14
Subtractive and additive fabrication methods can be used to
manufacture physical prototypes. Whereas subtractive manu-
facturing is done via numerically controlled machining similar
to a milling process to manufacture small objects, additive man-
ufacturing is based on the decomposition of 3D computer model
data into thin cross-sectional layers, followed by physical for-
mation and stacking of these layers into 3D forms.15
The development of computer-aided design and computer-
aided manufacturing (CAD/CAM) relies on data acquisition,
data processing, and manufacturing. The data in our case were
obtained from computer tomography (CT) scans of our pa-
tient at 1 mm slice intervals (resolution). The data from the
CT scanner were available as DICOM (digital imaging and
communications in medicine) files, which have to be converted
into .stl (standard triangulation language) files, to then be used
to input into our RP system. For us to do this, we used a
computer program known as MIMICS (Materialise interactive
medical image control system; Materialise, Leuven, Belgium),
which was able to segment the image and provide a clearer
representation of our area of interest. This software also allows
one to alter the gray-scale values from the DICOM images so
as to differentiate between soft tissue and bone.
The segmentation of the CT scans was performed by engi-
neers at the Centre for Rapid Prototyping and Manufacturing
(CRPM, Bloemfontein, South Africa), where a team of engi-
neers produced our 3D model on a laser sintering machine
(P385, EOS, Krailling, Germany). Selective laser sintering cre-
ates 3D models by fusing powdered materials with a carbon
dioxide (CO2) laser. The powdered material, available to us
at a thickness of 150 µm, was a polyamide material known
as PA2200 (EOS). This is a nylon-based material specifically
formulated to meet FDA requirements and is thus suitable for
medical use. This powdered material is spread by a roller over
the surface of a build cylinder. A piston in the cylinder moves
down one object layer thickness at a time to accommodate a
new layer of powder. A laser beam traces over the surface of
tightly compacted powder, thus elevating the temperature of
the powder to its melting point. This then fuses the particles
together, and once all the layers are fused together it forms a
solid mass, which in our case was our 3D model (Fig 6).
This model was essential to our planning, because we were
able to identify the boundaries and fixation areas of our planned
titanium frame (implant). The 3D skull data from our CT scans
were then imported into another software program, 3-MATIC
(Materialise). This program is truly unique in that it is capable
of combining CAD tools with pre-processing (meshing) capa-
bilities. It allows one to conduct thorough 3D measurements
and analyses, and design implants and surgical guides specific
to each patient. This allowed us to design the implant to be
manufactured for our patient (Fig 7).
This design was printed in resin on an Objet Connex 350
machine (Stratasys, Frankfurt, Germany) and positioned onto
our original 3D model to ensure a precision fit. With our 3-
MATIC software we were also able to design a custom drill
guide for our surgeons, so that our fixation holes were placed
at the correct angulation and where most suitable bone was
located. In this process, we arrived at a total of 21 fixating
holes that would anchor our implant with 21 corresponding
cortical screws (Fig 8).
Our implant design was transferred as an .stl file to a direct
metal laser sintering machine (EOSINT M280; EOS), which
was able to manufacture our solid implant via a similar laser sin-
tering process out of biocompatible titanium powder (titanium-
6Al-4V) of particle size < 40 µm (Fig 9). This implant was
trimmed and polished, after which the fitting surfaces of the
implant were treated in much the same way as dental implants,
including surface abrasion, to achieve possible cortical osseoin-
tegration. This procedure involved post machining and thread
cutting by Southern Implants (Irene, South Africa). The en-
tire process from design to manufacture took 10 working days,
with the cost amounting to around $5000, for which we obtained
sponsorship from our national research foundation, CRPM, and
Materialise (Leuven, Belgium).
Journal of Prosthodontics 00 (2016) 1–6 C© 2016 by the American College of Prosthodontists 5
Midfacial Defect Reconstruction via Additive Manufacturing Fernandes et al
Our facial implant was placed intraoperatively and fixated as
per our design with 21 cortical screws (Fig 10). A poly(vinyl
siloxane) impression (President; Whaledent, Cuyahoga Falls,
OH) was also taken at this time with the implant in place for
the manufacturing of a maxillary denture and a magnet-retained
silicone facial prosthesis. After 3 days, the finished maxillary
denture’s fitting surface was fitted and lined with a soft den-
ture base material (Molloplast-B; Buffalo Dental Manufactur-
ing, Syosset, NY) to act as a shock absorber during function
(Fig 11), and our definitive facial prosthesis was delivered
(Fig 12).
Conclusion
Malignant peripheral nerve sheath tumors of the trigeminal
nerve are exceedingly rare. To our knowledge this is the first
case where additive manufacturing techniques were used in
manufacturing a custom titanium implant for the reconstruction
of an extensive midfacial defect. Our patient has subsequently
adapted well to her facial implant and prosthesis, and has been
free of recurrent tumor for 6 months.
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